InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
2
T+90 hit rate
43%
T+90 mean return
+3.3%
Across 7 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the full record of transactions filed by POLEWACZYK JAMES F, Directeur Exécutif. Officer active across 1 company, notably Idexx Laboratories INC /de. In total, 12 reports have been logged. Split: 0 buy · 2 sells. Total volume traded: €5.2m. Activity tracked since 28 May 2021. The latest transaction was disclosed on 6 March 2024 (Levée d'options). Regulator: SEC (Form 4). All data is openly available.
Declarations12 total
755 shares@ US$206.941.9% of flowCommon StockSEC:0000874716-24-000065:0
126 shares0Common StockSEC:0000874716-24-000041:0
4,956 shares@ US$206.9412.7% of flowCommon StockSEC:0000874716-23-000145:0
2,627 shares@ US$68.752.2% of flowCommon StockSEC:0000874716-23-000113:0
126 shares0Common StockSEC:0001567619-23-003221:0
150 shares0Common StockSEC:0001567619-22-004785:0
4,595 shares@ US$633.0034.2% of flowCommon StockSEC:0001567619-21-021392
4,595 shares@ US$633.000.0048% mcap41.1% of flowCommon StockSEC:0001567619-21-021392:0
522 shares0Common StockSEC:0001567619-21-016332:0
522 shares0Common StockSEC:0001567619-21-016332
10,000 shares@ US$67.858.9% of flowCommon StockSEC:0001567619-21-011452
10,000 shares@ US$67.850.0010% mcap8.9% of flowCommon StockSEC:0001567619-21-011452:0
12 of 12 declarations
About POLEWACZYK JAMES F
POLEWACZYK JAMES F serves as Executive Vice President at IDEXX Laboratories Inc. In this role, he is responsible for managing operations and the company's strategy. His expertise in the sector is essential in supporting growth and innovation.
